Rubra Medicaments has informed that a Board Meeting of the Directors of the Company is scheduled to be held on November 10, 2016, to discuss and approve the unaudited Financial Result for the quarter and half year ended on September 30, 2016.
The above information is a part of company’s filings submitted to BSE.